Predictors of Regional Variations in Hospitalizations Following Emergency Department Visits for Atrial Fibrillation - 23/10/13
Abstract |
The emergency department (ED) is often where atrial fibrillation (AF) is first detected and acutely treated and affected patients dispositioned. We used the Nationwide Emergency Department Sample to estimate the percentage of visits resulting in hospitalization and investigate associations between patient and hospital characteristics with hospitalization at the national and regional levels. We conducted a cross-sectional study of adults with AF listed as the primary ED diagnosis in the 2007 to 2009 Nationwide Emergency Department Sample. We performed multivariate logistic regression analyses investigating the associations between prespecified patient and hospital characteristics with hospitalization. From 2007 to 2009, there were 1,320,123 weighted ED visits for AF, with 69% hospitalized nationally. Mean regional hospitalization proportions were: Northeast (74%), Midwest (68%), South (74%), and West (57%). The highest odds ratios for predicting hospitalization were heart failure (3.85, 95% confidence interval [CI] 3.66 to 4.02), chronic obstructive pulmonary disease (2.47, 95% CI 2.34 to 2.61), and coronary artery disease (1.65, 95% CI 1.58 to 1.73). After adjusting for age, privately insured (0.77, 95% CI 0.73 to 0.81) and self-pay (0.77 95% CI 0.66 to 0.90) patients had lower odds compared with Medicare recipients, whereas Medicaid (1.21, 95% CI 1.11 to 1.32) patients tended to have higher odds. Patients living in low-income zip codes (1.18, 95% CI 1.12 to 1.25) and patients treated at large metropolitan hospitals (1.75, 95% CI 1.59 to 1.93) had higher odds. In conclusion, our analysis showed considerable regional variation in the management of patients with AF in the ED and in associations between patient socioeconomic and hospital characteristics with ED disposition; adapting best practices from among these variations in management could reduce hospitalizations and health-care expenses.
Le texte complet de cet article est disponible en PDF.Plan
No industry financial support or compensation has been or will be received for conducting this study. Dr. Barrett and this study are funded by NIH grant K23 HL102069 from the National Heart, Lung and Blood Institute, Bethesda, MD. Dr. Self is supported in part by an NIH grant KL2TR000446 from the National Center for Advancing Translational Sciences. Dr. McNaughton is supported by NIH grant HL1K12HL109019 from the National Heart, Lung and Blood Institute, Bethesda, Maryland. Dr. Collins is supported by NIH grant K23HL085387 from the National Heart, Lung and Blood Institute, Bethesda, Maryland. Dr. Storrow is supported by NIH grant K12HL1090 and UL1TR000445 from the National Heart, Lung and Blood Institute, Bethesda, Maryland. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
|
See page 1415 for disclosure information. |
Vol 112 - N° 9
P. 1410-1416 - novembre 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?